ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -18 مورد

Prevalence of skeletal and biochemical abnormalities in different stages of pediatric chronic kidney disease

Prevalence of skeletal and biochemical abnormalities in different stages of pediatric chronic kidney disease
Prevalence of abnormalities related to CKD-MBD, based on studies in 52 patients 2 to 21 years of age with predialysis CKD. The mineralization defect was defined as an abnormal accumulation of osteoid (osteoid volume) in combination with a delayed osteoid maturation time. Increased PTH and FGF23 values were defined as those above the range determined in healthy individuals.
CKD: chronic kidney disease; CKD-MBD: chronic kidney disease mineral and bone disorder; FGF23: fibroblast growth factor 23; PTH: parathyroid hormone.
Reproduced with permission from Wolter Kluwer Health, Inc.: Wesseling-Perry K, Pereira RC, Tseng CH, et al. Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol 2011; 7(1):146-152. Copyright © The Authors. https://journals.lww.com/cjasn/pages/default.aspx.
Graphic 147000 Version 1.0